Evaluating the effect of melatonin compared to duloxetine in the treatment of chemotherapy-induced neuropathy (CINP): a clinical trial

计划入组 60 人

Proof of Principle Study Evaluating Gonyautoxins NEURO SERUM, on Chemotherapy-induced Peripheral Neuropathy

计划入组 52 人 · 首次发布于 2021 年 9 月 22 日

ciNPT in Autologous DIEP Flap Breast Reconstruction

计划入组 114 人 · 首次发布于 2023 年 6 月 18 日

Cinpanemab

VINP-28

CIN-209

CinPhloro Pharma, LLC

United States

Dogwood Therapeutics Initiates Phase 2b Trial of Halneuron® for Chemotherapy-Induced Neuropathic Pain

Dogwood Therapeutics Converts $19.5M Debt to Equity, Advances Phase 2b Trial of Non-Opioid Pain Treatment

Dogwood Therapeutics' Novel Pain Drug Halneuron® Drives 368% Stock Rally Amid Phase 2b Trial Launch